Associate Director, WW Medical Learning, Hematology

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it. At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, haematology, cardiovascular disease, immunology and neuroscience – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference. The WW Medical Learning Team plays a critical role in ensuring that healthcare providers are educated on the appropriate use of BMS medicines and have the information they need to improve outcomes for their patients. We develop and deploy strategies, tools, education, and skill building to empower Home Office Medical (HOM) and Field Medical (FM) teams across the globe to perform effectively and compliantly, ensuring high quality scientific exchange with the healthcare community.   What we are looking for:   WW Medical Learning is seeking a strategic leader to own the scientific learning agenda for BMS Hematology across WW/International Markets. This is predominantly a strategy-setting role: the Associate Director defines what FM and HOM teams globally need to know and be able to do in order to deliver trusted, high-impact scientific exchange – and builds the multi-year plans, partnerships, and governance model that make that possible. The Associate Director, WW/International Markets Medical Learning, translates the medical mission into a scientific learning strategy that positions FM and HOM as the trusted partner of choice to a broad set of stakeholders – driving scientific exchange and insight generation that create measurable medical impact, advance science, and enhance patient access to our medicines. Strategic Remit & Key Relationships: Reporting to the Director, WW/International Markets Medical Learning, this role holds an enterprise-wide view of the training needs of WW/International Markets FM and HOM teams and is accountable for shaping how those needs are met in partnership with WW Medical Learning and WW Commercialisation Learning. Success depends on building and governing senior-level relationships across WW Medical Affairs, International Markets Medical Enablement, the WW Commercialisation Learning Centre of Excellence, Medical Excellence, and US Medical Learning – aligning investment, content strategy, and delivery models with the strategic priorities of the WW medical matrix. This is a home office-based role with the ability to travel (up to ~10% based on requirements). .   Strategic Accountabilities: Own the multi-year scientific learning strategy for WW/International Markets hematology translating medical and commercial priorities into a coherent roadmap that governs how FM and HOM capability is built and sustained. Set the strategic framework for launch readiness, defining the standards, milestones, and governance that ensure FM and HOM teams globally are positioned to support priority clinical trials and major data readouts ahead of need. Architect the WW Medical learning approach to scientific data education at major medical congresses – establishing the strategic model for embargoed data readiness, post-congress contextualization, and knowledge-retention systems adopted across international markets. Build and govern a strategic partnership model across WW Medical Affairs, US Medical Learning, the WW Commercialisation Learning Centre of Excellence, Medical Excellence, and International Markets Medical Enablement teams, ensuring learning investment is concentrated against the highest-impact business priorities and content is leveraged rather than duplicated. Champion innovation and AI, in scientific education, evaluating and introducing new learning modalities, technologies, and adult-learning methodologies that raise the bar for the broader WW Medical Learning function. Define the strategic model for scientific onboarding and continuous learning journeys for international FM/HOM teams – ensuring consistency, scalability, and reuse of content developed for first market launches across subsequent worldwide launches. Set the strategy for measuring learning effectiveness, using training needs assessments and stakeholder feedback to shape where the function invests next, and advising the Director, WW/International Markets Medical Learning accordingly. Act as a strategic business partner with senior HOM and FM leadership to establish governance around training cadence – protecting field capacity for core activities while ensuring the organisation remains scientifically ready. Collaborate with International Market Medical Enablement team for deployment of scientific/skills resources Work closely with US Medical Learning and International Market Medical Enablement teams to support strategic alignment in education plans and resource development, leveraging and modifying content developed in support of first market launches for subsequent market launches for worldwide usage.  Direct resourcing and vendor strategy for the therapeutic area, ensuring third-party support is deployed against the highest-priority strategic initiatives. Align all trainings with medical strategic imperatives, medical communication topics, scientific narratives, and core competencies Act as a thought partner and advisor to the Director on the overall prioritisation, and evolution of the WW/International Mark